Oral and salivary parameters in patients with rheumatic diseases

References

• Holmstrup P, Poulsen A, Andersen L, Skuldbol T, Fiehn N-E. Oral infections and systemic diseases. Dent Clin N Am 2003; 47: 575–98
   PubMedGoogle Scholar
• Mercado F, Marshall R I, Klestov A C, Bartold P M. Is there a relationship between rheumatoid arthritis and periodontal disease?. J Clin Periodontol 2000; 27: 267–72
   PubMed Web of Science ®Google Scholar
• Käber U, Gleissner C, Dehne F, Michel A, Willershausen-Zönnchen B, Bolten W. Risk for periodontal disease in patients with longstanding rheumatoid arthritis. Arthritis Rheum 1997; 40: 2248–51
   PubMed Web of Science ®Google Scholar
• Helenius L MJ, Hietanen J, Helenius I, Kautiainen H, Piirainen H, Paimela L, et al. Focal sialadenitis in patients with ankylosing spondylitis and spondyloarthropathy: a comparison with patients with rheumatoid arthritis or mixed connective tissue disease. Ann Rheum Dis 2001; 60: 744–9
   PubMed Web of Science ®Google Scholar
• Guggenheimer J, Moore P. Xerostomia etiology, recognition and treatment. J Am Dent Assoc 2003; 134: 61–9
   PubMed Web of Science ®Google Scholar
• Davies J D, Berry H, Bacon P A, Issa M A, Schofield J J. Labial sialadenitis in Sjögren's syndrome and in rheumatoid arthritis. J Pathol 1973; 109: 307–14
   PubMed Web of Science ®Google Scholar
• Whaley K, Chisholm D M, Williamson J, Dick W C, Nuki G, Buchanan W W. Sjögren's syndrome in psoriatic arthritis, ankylosing spondylitis and Reiter's syndrome. Acta Rheum Scand 1971; 17: 105–14
   PubMedGoogle Scholar
• Konttinen Y T, Tuominen S, Piirainen H, Könönen M H, Wolf J E, Hietanen J H, et al. Signs and symptoms in masticatory system in ten patients with mixed connective tissue disease. Scand J Rheumatol 1990; 19: 363–73
   PubMed Web of Science ®Google Scholar
• Brandt J, Rudwaleit M, Eggens U, Mertz A, Distler A, Sieper J, et al. Increased frequency of Sjögren's syndrome in patients with spondyloarthropathy. J Rheumatol 1998; 25: 718–24
   PubMed Web of Science ®Google Scholar
• Ben-Aryeh H, Szargel R, Gutman D. Salivary IgA in Sjögren patients. Int J Oral Surg 1983; 12: 120–3
   PubMedGoogle Scholar
• Tishler M, Yaron I, Shirazi I, Yaron M. Saliva: an additional diagnostic tool in Sjögren's syndrome. Semin Arthritis Rheum 1997; 27: 173–9
   PubMed Web of Science ®Google Scholar
• Van der Reijden W A, van der Kwaak J S, Veerman E CI, Nieuw Amerongen A V. Analysis of the concentration and output of whole salivary constituents in patients with Sjögren's syndrome. Eur J Oral Sci 1996; 104: 335–40
   PubMed Web of Science ®Google Scholar
• Atkinson J, Fox P. Sjögren's syndrome: oral and dental considerations. J Am Dent Assoc 1993; 124: 74–86
   PubMed Web of Science ®Google Scholar
• Daniels T E, Whitcher J P. Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca: analysis of 618 patients with suspected Sjögren's syndrome. Arthritis Rheum 1994; 37: 869–77
   PubMed Web of Science ®Google Scholar
• Mandel I D, Baurmash H. Sialochemistry in Sjögren's syndrome. Oral Surg 1976; 41: 182–7
   PubMedGoogle Scholar
• Arnett F C, Edworthy S M, Bloch D A, McShane D J, Fries J F, Cooper N S, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24
   PubMed Web of Science ®Google Scholar
• Alarcon-Segovia D, Cardiel M H. Comparison between three diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 1989; 16: 328–34
   PubMed Web of Science ®Google Scholar
• Van der Linden S, Valkenburg H A, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 361–8
   PubMed Web of Science ®Google Scholar
• Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, et al. The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum 1991; 34: 1218–27
   PubMed Web of Science ®Google Scholar
• Vitali C, Bombardieri S, Jonsson R, Moutsopoulos H M, Alexander E L, Carsons S E, et al. European study group on classification criteria for Sjögren's syndrome. Ann Rheum Dis 2002; 61: 554–8
   PubMed Web of Science ®Google Scholar
• Ainamo J, Barmes D, Beagrie G, Cutress T, Martin J, Sardo-Infirri J. Development of the World Health Organization (WHO) community periodontal index for treatment needs (CPITN). Int Dent J 1982; 32: 281–91
   PubMed Web of Science ®Google Scholar
• Vitali C, Moutsopoulos H M, Bombardieri S. The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome. Ann Rheum Dis 1994; 53: 637–47
   Google Scholar
• Meurman J H, Laine P, Keinänen S, Pyrhönen S, Teerenhovi L, Lindqvist C. Five-year follow-up of saliva in patients treated for lymphomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 83: 447–52
   PubMed Web of Science ®Google Scholar
• Leversuch C J, Collins D A, Charles P J, Bourke B E. Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic disease. Br J Rheumatol 1995; 34: 435–9
   PubMedGoogle Scholar
• Meurman J H, Rantonen P FJ. Salivary flow rate, buffering capacity, and yeast counts in 187 consecutive adult patients from Kuopio, Finland. Scand J Dent Res 1992; 102: 229–34
   Google Scholar
• Wahlfors J, Meurman J H, Vaisanen P, Alakujala P, Korhonen A, Torkko H, Jänne J. Simultaneous detection of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis by a rapid PCR method. J Dent Res 1995; 74: 1796–801
   PubMed Web of Science ®Google Scholar
• Webster D. Immediate reaction between bromocresol green and serum as a measure of albumin content. Clin Chem 1977; 23: 663–5
   PubMed Web of Science ®Google Scholar
• Lehtonen O P, Gråhn E M, Ståhlberg T H, Laitinen L A. Amount and avidity of salivary and serum antibodies against mutans streptococci in two groups of human subjects with different dental caries susceptibility. Infect Immun 1984; 43: 308–13
   PubMed Web of Science ®Google Scholar
• Najera M P, al-Hashimi I, Plemons J M, Rivera-Hidalgo F, Rees T D, Haghighat N, et al. Prevalence of periodontal disease in patients with Sjögren's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 83: 453–7
   PubMed Web of Science ®Google Scholar
• Spielman A, Ben-Aryeh H, Lichtig C, Szargel R, Gutman D, Scharf J, et al. Correlation between sialochemistry and lip biopsy in Sjögren's syndrome patients. Int J Oral Surg 1982; 11: 326–30
   PubMedGoogle Scholar
• Kalk W W, Vissink A, Spijkervet F K, Bootsma H, Kallenberg C G, Nieuw Amerongen A V. Sialometry and sialochemistry: diagnostic tools for Sjögren's syndrome. Ann Rheum Dis 2001; 60: 1110–16
   PubMed Web of Science ®Google Scholar
• Mandel I D. Sialochemistry in diseases and clinical situations affecting salivary glands. Crit Rev Clin Lab Sci 1980; 11: 321–66
   Web of Science ®Google Scholar
• Elkon K B, Gharavi A E, Patel B M, Hughes G R, Frankel A. IgA and IgM rheumatoid factors in serum, saliva and other secretions: relationship to immunoglobulin ratios in systemic sicca syndrome and rheumatoid arthritis. Clin Exp Immunol 1983; 52: 75–84
   PubMed Web of Science ®Google Scholar
• Nahir A M, Szargel R, Scharf J, Ben-Aryeh H, Laufer D, Scharf Y. Chemical analysis of whole saliva in Sjögren's syndrome. Ann Rheum Dis 1987; 46: 654–7
   PubMed Web of Science ®Google Scholar
• Baum B J. Neurotransmitter control of secretion. J Dent Res 1987; 66: 628–32
   PubMed Web of Science ®Google Scholar
• Ben-Aryeh H, Spielman A, Szargel R, Gutman D, Scharf J, Nahir M, et al. Sialochemistry for diagnosis of Sjögren's syndrome in xerostomic patients. Oral Surg 1981; 52: 487–90
   PubMedGoogle Scholar
• Lane H C, Callihan T R, Jaffe E S, Fauci A S, Moutsopoulos H M. Presence of intracytoplasmic IgG in the lymphocytic infiltrates of the minor salivary glands of patients with primary Sjögren's syndrome. Clin Exp Rheumatol 1983; 1: 237–9
   PubMed Web of Science ®Google Scholar
• Davis M J, Dawes P T, Beswick E, Lewin I V, Stanworth D R. Sulphasalazine therapy in ankylosing spondylitis: its effect on disease activity, immunoglobulin A and the complex immunoglobulin A-alpha-1-antitrypsin. Br J Rheumatol 1989; 28: 410–13
   PubMedGoogle Scholar
• Feltelius N, Hvatum M, Brandtzaeg P, Knutson L, Hällgren R. Increased jejunal secretory IgA and IgM in ankylosing spondylitis: normalization after treatment with sulfasalazine. J Rheumatol 1994; 21: 2076–81
   PubMed Web of Science ®Google Scholar
• Vaile J H, Meddings J B, Yacyshyn B R, Russell A S, Maksymovych W P. Bowel permeability and CD45RO expression on circulating CD20+B cells in patients with ankylosing spondylitis and their relatives. J Rheumatol 1999; 26: 128–35
   PubMed Web of Science ®Google Scholar